Evidence map›Paper›PMID 35127121›Full record

ArticleObesity science & practice2022

Lifestyle modification for weight loss: Effects on cardiorespiratory capacity in patients with class II and class III obesity.

Finn Wammer, Andrea Haberberger, Anita Dyb Linge, Tor Åge Myklebust, Sveinung Vemøy, Dag Arne Lihaug Hoff

Open access · goldAbstract read
In one paragraph

Article in Obesity science & practice, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Finn WammerCentre for Achievement and Rehabilitation Muritunet A/S Valldal Norway.ORCID https://orcid.org/0000-0002-8636-2090
Andrea HaberbergerCentre for Achievement and Rehabilitation Muritunet A/S Valldal Norway.
Anita Dyb LingeCentre for Achievement and Rehabilitation Muritunet A/S Valldal Norway.
Tor Åge MyklebustDepartment of Research and Innovation Møre & Romsdal Hospitsal Trust Ålesund Norway.
Sveinung VemøyCentre for Achievement and Rehabilitation Muritunet A/S Valldal Norway.
Dag Arne Lihaug HoffDepartment of Medicine Ålesund Hospital Møre & Romsdal Hospital Trust Ålesund Norway.
Centre Muraz · BFÅlesund Hospital · NONorwegian University of Science and Technology · NOVolda University College · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe prevalence of obesity has increased worldwide. Obesity affects the lungs and airways, limits peak oxygen uptake, and hampers physical performance; however, objective data are scarce. Does lifestyle modification for weight loss (LM) have an impact on cardiorespiratory capacity (CRC) in patients with class II and class III obesity?

methodThis was a single-center prospective 2-year follow-up pilot study. Four separated stays in the inpatient specialized medical center Muritunet with an integrated approach to LM, including an individual plan on diet and physical activity (PA) goals. Furthermore, it included lectures and counseling on human anatomy and physiology, nutrition, physical exercise, and motivation, as well as daily PA. Cardiopulmonary and blood chemistry tests were conducted.

resultsSeventy-seven participants were included; however, 47% (

conclusionLifestyle modification for weight loss improves CRC in patients with class II and class III obesity.

Indexed as

cardiorespiratory capacitylifestyle modificationobesity class II and IIIquality of life

Identifiers

PMID35127121
PMCPMC8804912
OpenAlexW3177950276

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.